Blood transfusion therapy

In persons with Sickle Cell Disease who do not receive transfusions long-term and who are therefore at risk for hyperviscosity due to high percentages of circulating HbS-containing erythrocytes, avoid transfusion to a target hemoglobin level of more than 10 g/dL.

SNOMED_CT Problem=106063007 (PB0029); SNOMED_CT Cat-Tar=410357008 (CG0003, TG0050)

  • signs/symptoms-physical